ATE435425T1 - Verfahren zum nachweis des felinen immunschwächevirus - Google Patents

Verfahren zum nachweis des felinen immunschwächevirus

Info

Publication number
ATE435425T1
ATE435425T1 AT04783703T AT04783703T ATE435425T1 AT E435425 T1 ATE435425 T1 AT E435425T1 AT 04783703 T AT04783703 T AT 04783703T AT 04783703 T AT04783703 T AT 04783703T AT E435425 T1 ATE435425 T1 AT E435425T1
Authority
AT
Austria
Prior art keywords
deficiency virus
immuno deficiency
detecting feline
feline immuno
seq
Prior art date
Application number
AT04783703T
Other languages
English (en)
Inventor
Randall Groat
Quentin Tonelli
Original Assignee
Idexx Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idexx Lab Inc filed Critical Idexx Lab Inc
Application granted granted Critical
Publication of ATE435425T1 publication Critical patent/ATE435425T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • AIDS & HIV (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT04783703T 2003-09-11 2004-09-10 Verfahren zum nachweis des felinen immunschwächevirus ATE435425T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50198203P 2003-09-11 2003-09-11
US58410604P 2004-06-30 2004-06-30
PCT/US2004/029570 WO2005026733A1 (en) 2003-09-11 2004-09-10 Method and device for detecting feline immunodeficiency virus

Publications (1)

Publication Number Publication Date
ATE435425T1 true ATE435425T1 (de) 2009-07-15

Family

ID=34316504

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04783703T ATE435425T1 (de) 2003-09-11 2004-09-10 Verfahren zum nachweis des felinen immunschwächevirus

Country Status (9)

Country Link
US (3) US7776546B2 (de)
EP (2) EP1673633B9 (de)
JP (1) JP2007505320A (de)
AT (1) ATE435425T1 (de)
AU (1) AU2004273076B2 (de)
CA (1) CA2537429A1 (de)
DE (1) DE602004021829D1 (de)
ES (1) ES2327340T3 (de)
WO (1) WO2005026733A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4717009B2 (ja) * 2003-12-18 2011-07-06 アイデックス ラボラトリーズ インコーポレイテッド ネコ免疫不全ウイルスの検出のための方法と装置
AU2005215629B2 (en) * 2004-02-19 2009-01-29 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
US7285278B2 (en) * 2004-06-30 2007-10-23 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
WO2006011920A1 (en) * 2004-06-30 2006-02-02 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus (fiv) comprising the use of peptides derived from the v3 region of the fiv env protein
EP2309269B1 (de) 2004-09-08 2016-10-26 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Zusammensetzungen und verfahren zur detektion von hiv-1/hiv-2 infektion
US7291338B2 (en) * 2005-03-09 2007-11-06 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
US8809004B2 (en) 2010-04-02 2014-08-19 Idexx Laboratories, Inc. Detection of feline immunodeficiency virus
CN109734783A (zh) * 2018-12-26 2019-05-10 杭州爱谨生物科技有限公司 一种猫艾滋病毒重组蛋白及其制备方法和应用
JP6976621B1 (ja) * 2021-02-04 2021-12-08 株式会社Icst 検査器具、検査キットおよび検査方法

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4629783A (en) * 1985-04-29 1986-12-16 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease
US4879212A (en) 1986-04-02 1989-11-07 United Biomedical Inc. Peptide composition and method for the detection of antibodies to HTLV-III
US5118602A (en) * 1987-08-26 1992-06-02 The Regents Of The University Of California Feline T-lymphotropic lentivirus assay
CA1341439C (en) * 1987-08-26 2003-09-23 Niels C. Pedersen Feline t-lymphotropic lentivirus
US4900548A (en) * 1987-11-13 1990-02-13 Harvard University Use of diethylcarbamazine to enhance antigen-antibody and antigen-host immune cell interactions
JPH0211524A (ja) 1988-06-29 1990-01-16 Gen Corp:Kk オーエスキー病ワクチンの製造方法及び該ワクチン接種豚と自然感染豚との識別方法
CA1335880C (en) 1988-07-14 1995-06-13 Thomas P. O'connor Detection of an antibody and antigen in an immunoassay
US5219725A (en) 1988-12-05 1993-06-15 Idexx Laboratories Incorporated Monoclonal antibodies to feline-t-lymphotropic lentivirus
US5177014A (en) * 1988-12-05 1993-01-05 Idexx Laboratories, Inc. Monoclonal antibodies to feline-T-lymphotropic lentivirus
WO1990013573A1 (en) 1989-05-08 1990-11-15 Idexx Corporation Polypeptides of feline t-cell lymphotropic lentivirus
FR2669338A1 (fr) 1990-11-21 1992-05-22 Centre Nat Rech Scient Fragments peptidiques issus de la proteine externe du vif, anticorps antifragments, application de ceux-ci au diagnostic et/ou au traitement de l'immunodeficience feline.
US6228608B1 (en) 1991-02-28 2001-05-08 Aquila Biopharmaceuticals, Inc. Recombinant FIV glycoprotein 160 and P24 gag protein
AU667669B2 (en) 1991-06-14 1996-04-04 Idexx Laboratories, Inc. Detection of mammalian immunodeficiency viruses
WO1993001304A1 (en) 1991-07-10 1993-01-21 Synbiotics Corporation Synthetic peptides related to fiv-env proteins
US5726010A (en) 1991-07-31 1998-03-10 Idexx Laboratories, Inc. Reversible flow chromatographic binding assay
US5736378A (en) * 1991-09-12 1998-04-07 The Scripps Research Institute Molecular cloning and characterization of the feline immunodeficiency virus isolate PPR
ATE278018T1 (de) * 1992-06-16 2004-10-15 Centre Nat Rech Scient Nukleotid- und peptidsequenzen des immunschwächevirus der katze, isolat wo und anwendungen der sequenzen in der diagnostik und zur verhinderung der infektion
GB9215232D0 (en) 1992-07-17 1992-09-02 Pitman Moore Inc Vaccines
GB9219936D0 (en) 1992-09-21 1992-11-04 Pitman Moore Inc Vaccines
US5462852A (en) * 1992-10-28 1995-10-31 The Government Of The United States Of America, As Represented By The Secretary, Dhhs HIV Nucleocapsid protein capture assay and method of use
DE4242475A1 (de) 1992-12-16 1994-06-23 Suspa Compart Ag Führungsbuchse, insbesondere für längenverstellbare Stuhl-Säule und Stuhl-Säule mit derartiger Führungsbuchse
JPH07159408A (ja) 1993-12-09 1995-06-23 Biseibutsu Kagaku Kenkyusho:Kk オーエスキー病ウイルス感染抗体識別用抗原
US5576177A (en) 1994-03-09 1996-11-19 St. Jude Children's Research Hospital Bioassay for reverse transcriptase inhibitors
US5833993A (en) 1994-04-29 1998-11-10 Pharmacia & Upjohn Company Feline immunodeficiency virus vaccine
FR2721031B1 (fr) 1994-06-09 1996-07-26 Centre Nat Rech Scient Fragment peptidique spécifique du virus de l'immunodéficience féline (VIF) et son utilisation comme réactif de diagnostic.
CN1148578C (zh) * 1994-07-25 2004-05-05 罗切诊断学有限公司 免疫测定特异抗体的方法、所用试剂、抗原及其用途
US5675056A (en) 1995-03-09 1997-10-07 Vance; Murray A. Incandescent waste disposal system and method
FR2732346B1 (fr) 1995-03-27 1997-05-30 Centre Nat Rech Scient Proteines mutees, codees par un gene env mute de lentivirus, fragments peptidiques inclus dans lesdites proteines, vecteurs d'expression exprimant lesdites proteines mutees et leurs applications
US5849303A (en) 1995-06-07 1998-12-15 American Home Products Corporation Recombinant feline Immunodeficiency virus subunit vaccines employing baculoviral-expressed envelope glycoproteins derived from isolate NCSU-1 and their use against feline immunodeficiency virus infection
US5820869A (en) 1995-06-07 1998-10-13 American Home Products Corporation Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
US6300118B1 (en) 1995-06-07 2001-10-09 American Home Products Corporation Plasmids comprising a genetically altered feline immunodeficiency virus genome
US6254872B1 (en) * 1995-08-25 2001-07-03 University Of Florida Multi-subtype FIV vaccines
BR9610343A (pt) 1995-08-25 1999-12-21 Univ Florida Vacinas de subtipos múltiplos para fiv
US6077662A (en) * 1996-11-27 2000-06-20 Emory University Virus-like particles, methods and immunogenic compositions
US6331616B1 (en) 1997-03-05 2001-12-18 North Carolina State University Nucleic acids obtained from the envelope coding region of feline immunodeficiency virus molecular clone designated JSY3
EP0887412B1 (de) 1997-05-26 2003-10-15 Akzo Nobel N.V. Rekombinanter Birnavirusimpfstoff
FR2769916B1 (fr) 1997-10-17 2000-12-01 Centre Nat Rech Scient Peptides issus du gene env du virus de l'immunodeficience feline et leurs applications immunoprotectrices et vaccinales
FR2771011B1 (fr) 1997-11-17 2000-01-28 Hippocampe Obtention de vaccins destines a prevenir les effets pathogenes associes a une infection retrovirale
CA2312049A1 (en) 1997-12-05 1999-06-17 The University Of New Mexico Method for purifying heat shock peptides complexes
US6284253B1 (en) 1998-01-29 2001-09-04 Cornell Research Foundation, Inc. Feline immunodeficiency virus (FIV) nucleotide sequence
US6458528B1 (en) 1998-05-15 2002-10-01 Idexx Laboratories, Inc. Diagnosis of feline immunodeficiency virus infection using ENV/GAG polypeptide markers
US6764676B1 (en) 1998-08-24 2004-07-20 Pfizer Inc. Compositions and methods for protecting animals from lentivirus-associated disease such as feline immunodeficiency virus
EP1074625A3 (de) * 1999-06-14 2002-01-02 Pfizer Products Inc. DNS impfstoff gegen das immunschwächevirus der Katze
AU6683400A (en) 1999-07-08 2001-01-30 Mologen Forschungs-, Entwicklungs- Und Vertriebs Gmbh Vaccine against lentiviral infections, such as the feline immune deficiency virus of the cat
CA2386239A1 (en) * 1999-10-04 2001-04-12 University Of Medicine And Dentistry Of New Jersey Methods for identifying rna binding compounds
US20040115621A1 (en) * 2000-02-18 2004-06-17 Allen Rodrigo Ancestral viruses and vaccines
FR2828687B1 (fr) 2001-08-17 2003-12-12 Hippocampe Nouveaux peptides et leur utilisation comme medicaments contre l'infection par le fiv chez le chat
JP2006528244A (ja) 2003-05-12 2006-12-14 ユニバーシティ オブ フロリダ リサーチ ファウンデーション，インコーポレイティド Ｆｉｖ感染予防接種のための材料と方法

Also Published As

Publication number Publication date
US7201903B2 (en) 2007-04-10
US20050058992A1 (en) 2005-03-17
US20110189651A1 (en) 2011-08-04
EP1673633A1 (de) 2006-06-28
EP1673633B9 (de) 2011-03-02
AU2004273076A1 (en) 2005-03-24
EP2107374A1 (de) 2009-10-07
ES2327340T3 (es) 2009-10-28
CA2537429A1 (en) 2005-03-24
DE602004021829D1 (de) 2009-08-13
AU2004273076B2 (en) 2008-02-14
US7776546B2 (en) 2010-08-17
EP1673633B1 (de) 2009-07-01
WO2005026733A1 (en) 2005-03-24
US20050058993A1 (en) 2005-03-17
JP2007505320A (ja) 2007-03-08

Similar Documents

Publication Publication Date Title
DK1476541T3 (da) Cytokin (zcytor17-ligand)
DK1562983T3 (da) Flere varianter af meningokok-protein NMB1870
DE60024558D1 (de) Verfahren und Vorrichtung zur Handhabung von Ausgabebogen, geeignet zum optimalen Anwählen des Auffangbehälters
ATE432470T1 (de) Verfahren zur unterscheidung des reizkolons von der entzündlichen darmerkrankung (inflammatory bowel disease, ibd) und zur überwachung von patienten mit ibd unter verwendung von endogenem gesamt-lactoferrin als marker
DE60014762D1 (de) Methode zum Nachweis von Ribonukleinsäuren
ATE388230T1 (de) Neisseria meningitidis antigene und zusammenstellungen
DE60027711D1 (de) Verbesserte vorrichtung zum nachweis von myokardischämie
DE60115653D1 (de) Verfahren zur Detektion von Emotionen, unter Verwendung von Untergruppenspezialisten
ATE532070T1 (de) Entzündungsmarker zum nachweis und zur prävention von diabetes mellitus
UA84284C2 (ru) Способы лечения, профилактики и диагностики инфекции helicobacter cerdo
DE602004029107D1 (de) System zum Sortieren und zur Reihenfolgeplanung von Postsendungen
WO2006059247A3 (en) VACCINES, COMPOSITIONS AND METHODS BASED ON STAPHYLOCOCCUS AUREUS IRON-REGULATED SURFACE DETERMINANTS IsdA, IsdB, and IsdC
ATE415175T1 (de) Ace2-aktivierung zur behandlung von herz, lungen, und nierenkrankheit und bluthochdruck
ATE435425T1 (de) Verfahren zum nachweis des felinen immunschwächevirus
DE60105335D1 (de) Verfahren zum Denaturieren von Allergenen unter Verwendung von Calcium- oder Strontiumsalzen
DE69734236D1 (de) Genetische marker und methoden zum detektion von escherichia coli serotype-0157:h7
ATE462001T1 (de) Markerproteine zur diagnose einer lebererkrankung und verfahren zur diagnose einer lebererkrankung damit
DE60043985D1 (de) "gen-fallen-vektor" und verfahren zum "einfangen" von genen mittels dieses vektors
ATA19172002A (de) Verfahren zum einbringen und verblasen von gesteinsstaub sowie vorrichtung zur durchführung dieses verfahrens
ATE356831T1 (de) Neuer galaninrezeptor
BR0210429A (pt) Circovìrus atenuado
DE60117297D1 (de) Genetischer test zur identifizierung von trägern komplexer vertebraler missbildungen in rindern
DE60010034D1 (de) Methode zur handhabung von 1,1,1,3,3-pentfluoropropan
DE60032293D1 (de) Lebende attenuierte bakterien zur verwendung als impfstoff
DE60210885D1 (de) Vorrichtung zum Melken von Tieren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties